your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Lisinopril and increased risk of stroke
Lisinopril and increased risk of stroke
In the ALLHAT trial, cumulative event rates for the development of stroke according to primary treatment with chlorthalidone, amlodipine, or lisinopril. Compared to chlorthalidone, there was a significant increase in the six year rate of stroke with lisinopril (6.3 versus 5.6 percent, relative risk 1.15 95 percent CI 1.02 to 1.30).
Data from The ALLHAT Officers, JAMA 2002; 288:2981.